Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP

Nabeel Azeem, Christopher J. Gostout, Mary Knipschield, Todd H. Baron

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background Patients with primary sclerosing cholangitis (PSC) have an increased lifetime risk of cholangiocarcinoma (CCA). Detection of localized CCA in patients with PSC may result in curative liver transplantation. Recently, high-resolution per-oral video cholangioscopy (PVCS) has become available and may be useful for evaluating for biliary dysplasia. Narrow-band imaging (NBI) has shown promising results in detecting dysplasia in the esophagus and colon, but its utility in the bile duct is unproven. Objective Evaluate NBI video PVCS in screening for dysplasia in patients with PSC. Design Prospective case series. Setting Tertiary-care referral center. Patients Patients with PSC undergoing ERCP between December 2008 and July 2010. Intervention ERCP with white-light and NBI PVCS and biopsy of suspicious lesions. Main Outcome Measurements Dysplasia detection. Results A total of 30 patients were enrolled. Median follow-up was 319.5 days. Four patients had a final diagnosis of CCA (2 extrahepatic, 2 intrahepatic). NBI visualized the 2 extrahepatic CCAs and allowed determination of tumor margins. The bile duct mucosa by NBI visual appearance in patients with PSC was variable. No correlation with CCA development could be determined. There was a 48% increase in suspicious lesions biopsied with NBI compared with white-light imaging, although NBI-directed biopsies did not improve the dysplasia detection rate. Limitations Small sample size, single center, referral bias. Conclusion NBI allowed visualization of tumor margins in CCA as compared with traditional fluoroscopy-based ERCP. An improvement in dysplasia detection in patients with PSC could not be demonstrated despite an increase in the biopsy rate. Additional experience is needed to assess the utility of NBI in screening for CCA in patients with PSC. (Clinical trial registration number: NCT00951327.)

Original languageEnglish (US)
JournalGastrointestinal Endoscopy
Volume79
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Narrow Band Imaging
Sclerosing Cholangitis
Endoscopic Retrograde Cholangiopancreatography
Cholangiocarcinoma
Bile Ducts
Biopsy
Tertiary Care Centers
Light
Fluoroscopy
Liver Transplantation
Sample Size
Esophagus
Neoplasms
Colon
Mucous Membrane
Referral and Consultation

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. / Azeem, Nabeel; Gostout, Christopher J.; Knipschield, Mary; Baron, Todd H.

In: Gastrointestinal Endoscopy, Vol. 79, No. 5, 2014.

Research output: Contribution to journalArticle

Azeem, Nabeel ; Gostout, Christopher J. ; Knipschield, Mary ; Baron, Todd H. / Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. In: Gastrointestinal Endoscopy. 2014 ; Vol. 79, No. 5.
@article{f051f55a864f43eea68800873fd723d0,
title = "Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP",
abstract = "Background Patients with primary sclerosing cholangitis (PSC) have an increased lifetime risk of cholangiocarcinoma (CCA). Detection of localized CCA in patients with PSC may result in curative liver transplantation. Recently, high-resolution per-oral video cholangioscopy (PVCS) has become available and may be useful for evaluating for biliary dysplasia. Narrow-band imaging (NBI) has shown promising results in detecting dysplasia in the esophagus and colon, but its utility in the bile duct is unproven. Objective Evaluate NBI video PVCS in screening for dysplasia in patients with PSC. Design Prospective case series. Setting Tertiary-care referral center. Patients Patients with PSC undergoing ERCP between December 2008 and July 2010. Intervention ERCP with white-light and NBI PVCS and biopsy of suspicious lesions. Main Outcome Measurements Dysplasia detection. Results A total of 30 patients were enrolled. Median follow-up was 319.5 days. Four patients had a final diagnosis of CCA (2 extrahepatic, 2 intrahepatic). NBI visualized the 2 extrahepatic CCAs and allowed determination of tumor margins. The bile duct mucosa by NBI visual appearance in patients with PSC was variable. No correlation with CCA development could be determined. There was a 48{\%} increase in suspicious lesions biopsied with NBI compared with white-light imaging, although NBI-directed biopsies did not improve the dysplasia detection rate. Limitations Small sample size, single center, referral bias. Conclusion NBI allowed visualization of tumor margins in CCA as compared with traditional fluoroscopy-based ERCP. An improvement in dysplasia detection in patients with PSC could not be demonstrated despite an increase in the biopsy rate. Additional experience is needed to assess the utility of NBI in screening for CCA in patients with PSC. (Clinical trial registration number: NCT00951327.)",
author = "Nabeel Azeem and Gostout, {Christopher J.} and Mary Knipschield and Baron, {Todd H.}",
year = "2014",
doi = "10.1016/j.gie.2013.09.017",
language = "English (US)",
volume = "79",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP

AU - Azeem, Nabeel

AU - Gostout, Christopher J.

AU - Knipschield, Mary

AU - Baron, Todd H.

PY - 2014

Y1 - 2014

N2 - Background Patients with primary sclerosing cholangitis (PSC) have an increased lifetime risk of cholangiocarcinoma (CCA). Detection of localized CCA in patients with PSC may result in curative liver transplantation. Recently, high-resolution per-oral video cholangioscopy (PVCS) has become available and may be useful for evaluating for biliary dysplasia. Narrow-band imaging (NBI) has shown promising results in detecting dysplasia in the esophagus and colon, but its utility in the bile duct is unproven. Objective Evaluate NBI video PVCS in screening for dysplasia in patients with PSC. Design Prospective case series. Setting Tertiary-care referral center. Patients Patients with PSC undergoing ERCP between December 2008 and July 2010. Intervention ERCP with white-light and NBI PVCS and biopsy of suspicious lesions. Main Outcome Measurements Dysplasia detection. Results A total of 30 patients were enrolled. Median follow-up was 319.5 days. Four patients had a final diagnosis of CCA (2 extrahepatic, 2 intrahepatic). NBI visualized the 2 extrahepatic CCAs and allowed determination of tumor margins. The bile duct mucosa by NBI visual appearance in patients with PSC was variable. No correlation with CCA development could be determined. There was a 48% increase in suspicious lesions biopsied with NBI compared with white-light imaging, although NBI-directed biopsies did not improve the dysplasia detection rate. Limitations Small sample size, single center, referral bias. Conclusion NBI allowed visualization of tumor margins in CCA as compared with traditional fluoroscopy-based ERCP. An improvement in dysplasia detection in patients with PSC could not be demonstrated despite an increase in the biopsy rate. Additional experience is needed to assess the utility of NBI in screening for CCA in patients with PSC. (Clinical trial registration number: NCT00951327.)

AB - Background Patients with primary sclerosing cholangitis (PSC) have an increased lifetime risk of cholangiocarcinoma (CCA). Detection of localized CCA in patients with PSC may result in curative liver transplantation. Recently, high-resolution per-oral video cholangioscopy (PVCS) has become available and may be useful for evaluating for biliary dysplasia. Narrow-band imaging (NBI) has shown promising results in detecting dysplasia in the esophagus and colon, but its utility in the bile duct is unproven. Objective Evaluate NBI video PVCS in screening for dysplasia in patients with PSC. Design Prospective case series. Setting Tertiary-care referral center. Patients Patients with PSC undergoing ERCP between December 2008 and July 2010. Intervention ERCP with white-light and NBI PVCS and biopsy of suspicious lesions. Main Outcome Measurements Dysplasia detection. Results A total of 30 patients were enrolled. Median follow-up was 319.5 days. Four patients had a final diagnosis of CCA (2 extrahepatic, 2 intrahepatic). NBI visualized the 2 extrahepatic CCAs and allowed determination of tumor margins. The bile duct mucosa by NBI visual appearance in patients with PSC was variable. No correlation with CCA development could be determined. There was a 48% increase in suspicious lesions biopsied with NBI compared with white-light imaging, although NBI-directed biopsies did not improve the dysplasia detection rate. Limitations Small sample size, single center, referral bias. Conclusion NBI allowed visualization of tumor margins in CCA as compared with traditional fluoroscopy-based ERCP. An improvement in dysplasia detection in patients with PSC could not be demonstrated despite an increase in the biopsy rate. Additional experience is needed to assess the utility of NBI in screening for CCA in patients with PSC. (Clinical trial registration number: NCT00951327.)

UR - http://www.scopus.com/inward/record.url?scp=84897992074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897992074&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2013.09.017

DO - 10.1016/j.gie.2013.09.017

M3 - Article

C2 - 24206748

AN - SCOPUS:84897992074

VL - 79

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 5

ER -